Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

By creating gene editors not found in nature, or optimizing existing editors, AI can improve the accuracy, effectiveness, and accessibility of gene editing.

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

Vertex Pharmaceuticals announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® (exagamglogene ...

Advancements and Projections in the Global Zebrafish for Research Market: Insights, Trends, Opportunities, and Recent DevelopmentsNew York, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Overview The Global ...

“Her groundbreaking research will push the boundaries of science and benefit humanity.” In 2008, Doudna’s nascent research on the function of CRISPR arrays in bacterial genomes and the Cas1 protein ...

"By enhancing our CRISPR expertise with AstraZeneca's novel nuclease ... and total cost of care across large populations in a wide array of conditions," said James Lu, MD, PhD, CEO, co-founder, Helix, ...

So CRISPR Therapeutics is also trying to modify the cells of the patients directly in the body with so-called “in-vivo” techniques. This either uses viruses as vectors of mRNA techniques not ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...

A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.